PL3303564T3 - Metody in vitro różnicowania neuronów dopaminowych śródmózgowia (mda) - Google Patents
Metody in vitro różnicowania neuronów dopaminowych śródmózgowia (mda)Info
- Publication number
- PL3303564T3 PL3303564T3 PL16804350T PL16804350T PL3303564T3 PL 3303564 T3 PL3303564 T3 PL 3303564T3 PL 16804350 T PL16804350 T PL 16804350T PL 16804350 T PL16804350 T PL 16804350T PL 3303564 T3 PL3303564 T3 PL 3303564T3
- Authority
- PL
- Poland
- Prior art keywords
- mda
- neurons
- methods
- vitro differentiation
- midbrain dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562169444P | 2015-06-01 | 2015-06-01 | |
US201562169379P | 2015-06-01 | 2015-06-01 | |
PCT/US2016/035312 WO2016196661A1 (en) | 2015-06-01 | 2016-06-01 | Methods of in vitro differentiation of midbrain dopamine (mda) neurons |
EP16804350.3A EP3303564B1 (en) | 2015-06-01 | 2016-06-01 | Methods of in vitro differentiation of midbrain dopamine (mda) neurons |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3303564T3 true PL3303564T3 (pl) | 2022-05-09 |
Family
ID=57441792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL16804350T PL3303564T3 (pl) | 2015-06-01 | 2016-06-01 | Metody in vitro różnicowania neuronów dopaminowych śródmózgowia (mda) |
Country Status (17)
Country | Link |
---|---|
US (2) | US10858625B2 (pl) |
EP (3) | EP3303564B1 (pl) |
JP (4) | JP6974180B2 (pl) |
KR (2) | KR20220020416A (pl) |
AU (2) | AU2016270793B2 (pl) |
CA (1) | CA2987617A1 (pl) |
DK (1) | DK3303564T3 (pl) |
ES (1) | ES2910032T3 (pl) |
HR (1) | HRP20220482T1 (pl) |
HU (1) | HUE058258T2 (pl) |
IL (2) | IL255992B (pl) |
LT (1) | LT3303564T (pl) |
PL (1) | PL3303564T3 (pl) |
PT (1) | PT3303564T (pl) |
RS (1) | RS63157B1 (pl) |
SI (1) | SI3303564T1 (pl) |
WO (1) | WO2016196661A1 (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019503703A (ja) * | 2016-02-05 | 2019-02-14 | メモリアル スローン ケタリング キャンサー センター | 幹細胞由来外胚葉系統前駆体を分化する方法 |
EP4328301A2 (en) * | 2016-08-16 | 2024-02-28 | FUJIFILM Cellular Dynamics, Inc. | Methods for differentiating pluripotent cells |
EP3614837A4 (en) * | 2017-04-26 | 2020-12-30 | Memorial Sloan-Kettering Cancer Center | READY-TO-USE CRYOPRESERVED CELLS |
US20200173983A1 (en) * | 2017-07-17 | 2020-06-04 | Miltenyi Biotec B.V. & Co. KG | A method for single cell protein expression profiling of floorplate mesencephalic dopaminergic progenitor cells |
WO2019032680A1 (en) * | 2017-08-08 | 2019-02-14 | Regents Of The University Of Minnesota | METHODS OF GENERATING AND USING ORGANOIDS AND ASSOCIATED CELLS |
CN114174498A (zh) * | 2019-05-23 | 2022-03-11 | 麦可林医院公司 | 用于帕金森氏病的自体细胞替代疗法 |
EP4038181A1 (en) | 2019-07-25 | 2022-08-10 | The Scripps Research Institute | Methods of identifying dopaminergic neurons and progenitor cells |
EP4021477A4 (en) * | 2019-08-29 | 2023-12-13 | Memorial Sloan Kettering Cancer Center | METHOD FOR GENERATING AND ISOLATING MID-DOPAMINE NEURONS |
JP2022549224A (ja) * | 2019-09-20 | 2022-11-24 | コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー | ダイレクトリプログラミングを用いる、誘導型ドーパミン作動性神経前駆細胞の製造方法 |
WO2021195426A1 (en) | 2020-03-25 | 2021-09-30 | Sana Biotechnology, Inc. | Hypoimmunogenic neural cells for the treatment of neurological disorders and conditions |
WO2021216622A1 (en) | 2020-04-21 | 2021-10-28 | Aspen Neuroscience, Inc. | Gene editing of gba1 in stem cells and method of use of cells differentiated therefrom |
WO2021216623A1 (en) | 2020-04-21 | 2021-10-28 | Aspen Neuroscience, Inc. | Gene editing of lrrk2 in stem cells and method of use of cells differentiated therefrom |
CN116635047A (zh) * | 2020-06-26 | 2023-08-22 | 米纳瓦生物技术公司 | 用于从多能干细胞衍生多巴胺能神经元的方法 |
CA3183958A1 (en) * | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Methods for deriving dopaminergic neurons from pluripotent stem cells |
WO2022216911A1 (en) * | 2021-04-07 | 2022-10-13 | FUJIFILM Cellular Dynamics, Inc. | Dopaminergic precursor cells and methods of use |
WO2023004370A1 (en) | 2021-07-21 | 2023-01-26 | Aspen Neuroscience, Inc. | Aav-based modulation of gba1 and related compositions and uses thereof |
US20230081881A1 (en) | 2021-07-21 | 2023-03-16 | Aspen Neuroscience, Inc. | Transposon-based modulation of gba1 and related compositions and uses thereof |
WO2023086894A1 (en) | 2021-11-12 | 2023-05-19 | Axent Biosciences Inc. | Methods for production of functional neurons |
WO2023201361A1 (en) | 2022-04-15 | 2023-10-19 | Aspen Neuroscience, Inc. | Methods of classifying the differentiation state of cells and related compositions of differentiated cells |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000068431A2 (en) | 1999-05-06 | 2000-11-16 | Mount Sinai School Of Medicine Of New York University | Dna-based steganography |
AU6319901A (en) * | 2000-05-17 | 2001-11-26 | Geron Corp | Neural progenitor cell populations |
AU2005278897A1 (en) * | 2004-09-02 | 2006-03-09 | Neuro Therapeutics Ab | Methods and materials relating to enhanced production of dopamine neurons |
WO2006071778A2 (en) * | 2004-12-23 | 2006-07-06 | Ethicon Incorporated | Treatment of parkinson's disease and related disorders using postpartum derived cells |
EP2422794A3 (en) | 2006-03-07 | 2013-03-13 | Geeta Shroff | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
WO2008008266A2 (en) | 2006-07-07 | 2008-01-17 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
WO2010096496A2 (en) | 2009-02-17 | 2010-08-26 | Memorial Sloan-Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
AU2011258634B2 (en) | 2010-05-25 | 2015-03-26 | Memorial Sloan-Kettering Cancer Center | Method of nociceptor differentiation of human embryonic stem cells and uses thereof |
US20110296542A1 (en) | 2010-05-28 | 2011-12-01 | Kevin Ka-Wang Wang | Exogenous matrix-supported topical application of stem cells to organ surface |
EP2773748B1 (en) * | 2011-11-04 | 2019-12-25 | Memorial Sloan Kettering Cancer Center | Midbrain dopamine (da) neurons for engraftment |
US20150159135A1 (en) | 2012-06-15 | 2015-06-11 | Baylor College Of Medicine | Perineurium Derived Adult Stem Cells and Methods of Use |
CA2910394A1 (en) | 2013-04-26 | 2014-10-30 | Memorial Sloan-Kettering Cancer Center | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
KR101696874B1 (ko) * | 2013-07-31 | 2017-01-16 | 한국생명공학연구원 | 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법 |
JP6419073B2 (ja) * | 2013-08-06 | 2018-11-07 | 武田薬品工業株式会社 | ドパミン神経細胞の製造方法 |
CN105849255A (zh) * | 2013-09-05 | 2016-08-10 | 国立大学法人京都大学 | 新的产多巴胺神经前体细胞诱导方法 |
WO2015077648A1 (en) | 2013-11-21 | 2015-05-28 | Memorial Sloan-Kettering Cancer Center | Specification of functional cranial placode derivatives from human pluripotent stem cells |
JP6718431B2 (ja) * | 2014-03-21 | 2020-07-08 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | 中脳ドーパミン作動性ニューロンの生産およびその使用方法 |
-
2016
- 2016-06-01 WO PCT/US2016/035312 patent/WO2016196661A1/en active Application Filing
- 2016-06-01 RS RS20220353A patent/RS63157B1/sr unknown
- 2016-06-01 EP EP16804350.3A patent/EP3303564B1/en active Active
- 2016-06-01 ES ES16804350T patent/ES2910032T3/es active Active
- 2016-06-01 LT LTEPPCT/US2016/035312T patent/LT3303564T/lt unknown
- 2016-06-01 CA CA2987617A patent/CA2987617A1/en active Pending
- 2016-06-01 EP EP22176877.3A patent/EP4079314A1/en active Pending
- 2016-06-01 PT PT168043503T patent/PT3303564T/pt unknown
- 2016-06-01 SI SI201631535T patent/SI3303564T1/sl unknown
- 2016-06-01 HU HUE16804350A patent/HUE058258T2/hu unknown
- 2016-06-01 PL PL16804350T patent/PL3303564T3/pl unknown
- 2016-06-01 JP JP2017562028A patent/JP6974180B2/ja active Active
- 2016-06-01 KR KR1020227003399A patent/KR20220020416A/ko active IP Right Grant
- 2016-06-01 AU AU2016270793A patent/AU2016270793B2/en active Active
- 2016-06-01 KR KR1020177037050A patent/KR102358878B1/ko active IP Right Grant
- 2016-06-01 DK DK16804350.3T patent/DK3303564T3/da active
- 2016-06-01 EP EP22157782.8A patent/EP4070803A1/en active Pending
- 2016-06-01 HR HRP20220482TT patent/HRP20220482T1/hr unknown
-
2017
- 2017-11-22 US US15/820,941 patent/US10858625B2/en active Active
- 2017-11-29 IL IL255992A patent/IL255992B/en unknown
-
2020
- 2020-06-12 JP JP2020102332A patent/JP2020146060A/ja active Pending
- 2020-11-09 US US17/093,126 patent/US20210123018A1/en active Pending
-
2021
- 2021-12-20 JP JP2021205897A patent/JP2022031961A/ja not_active Withdrawn
-
2022
- 2022-03-20 IL IL291532A patent/IL291532A/en unknown
- 2022-09-09 AU AU2022228216A patent/AU2022228216A1/en active Pending
-
2023
- 2023-11-02 JP JP2023188483A patent/JP2023181494A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4070803A1 (en) | 2022-10-12 |
AU2016270793B2 (en) | 2022-06-09 |
EP3303564A1 (en) | 2018-04-11 |
KR20180014743A (ko) | 2018-02-09 |
AU2022228216A1 (en) | 2022-10-06 |
WO2016196661A1 (en) | 2016-12-08 |
JP6974180B2 (ja) | 2021-12-01 |
JP2018522538A (ja) | 2018-08-16 |
PT3303564T (pt) | 2022-06-02 |
IL255992B (en) | 2022-04-01 |
ES2910032T3 (es) | 2022-05-11 |
CA2987617A1 (en) | 2016-12-08 |
SI3303564T1 (sl) | 2022-07-29 |
KR20220020416A (ko) | 2022-02-18 |
EP3303564A4 (en) | 2018-10-31 |
LT3303564T (lt) | 2022-05-10 |
JP2020146060A (ja) | 2020-09-17 |
HRP20220482T1 (hr) | 2022-07-08 |
JP2022031961A (ja) | 2022-02-22 |
EP4079314A1 (en) | 2022-10-26 |
JP2023181494A (ja) | 2023-12-21 |
IL255992A (en) | 2018-01-31 |
US20180094242A1 (en) | 2018-04-05 |
KR102358878B1 (ko) | 2022-02-08 |
US20210123018A1 (en) | 2021-04-29 |
US10858625B2 (en) | 2020-12-08 |
EP3303564B1 (en) | 2022-02-23 |
AU2016270793A1 (en) | 2017-12-14 |
DK3303564T3 (da) | 2022-04-04 |
IL291532A (en) | 2022-05-01 |
HUE058258T2 (hu) | 2022-07-28 |
RS63157B1 (sr) | 2022-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL291532A (en) | Processes for in vitro differentiation of midbrain dopamine neurons | |
EP3238481A4 (en) | Method and apparatus of latency measurement for lte-wlan aggregation | |
DK3119881T3 (da) | Production of midbrain dopaminergic neurons and methods for the use thereof | |
SG11201610052TA (en) | Photo-controlled removal of targets in vitro and in vivo | |
HK1257761A1 (zh) | 用於測量限制的配置的方法和裝置 | |
EP3128045A4 (en) | Cylinder plating apparatus and method | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
HK1214767A1 (zh) | 片劑形式的藥物組合物及其製造方法 | |
HK1243400A1 (zh) | 維生素d2和d3的改進的生產方法 | |
PT3503885T (pt) | Composição farmacêutica e métodos de utilização | |
GB201513084D0 (en) | Apparatus for measure of quantity and associated method of manufacturing | |
GB201412554D0 (en) | In vitro mesodermal differentiation | |
HUP1400543A2 (hu) | Eljárás és köztitermék apixaban elõállítására | |
IL254732A0 (en) | In vitro preservation of therapeutic cells | |
HUP1500647A2 (en) | Intermediate of baricitinib and process for its preparation | |
GB201416858D0 (en) | Methods of in Vitro Oocyte Development | |
TWM490537U (en) | Structure of stand | |
ZA201608823B (en) | Processes for the preparation of azd5363 and novel intermediate used therein | |
GB201612453D0 (en) | Methods and apparatus for measuring deformation | |
EP3230440A4 (en) | Compositions and methods for neuronal differentiation of cells | |
GB201406801D0 (en) | MRI Apparatus and methods | |
GB2526175B (en) | Design method and apparatus for the manufacture of an article | |
GB2533406B (en) | Methods and apparatus for manufacture of ophthalmic lenses | |
AU2014904953A0 (en) | Compositions and methods for neuronal differentiation of cells | |
GB201403177D0 (en) | Preparation and analysis of iminosugar acids |